The AHSN Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Mind over bladder - Prevent harm associated with excessive or inappropriate anticholinergic burden, can be viewed here. For more information about the polypharmacy programme, please visit https://www.ahsnnetwork.com/programmes/medicines/polypharmacy/

1. Intervention Total
Deprescribed medication 48
Monitoring requested 20
Additional meds prescribed 14
Dose reductions/increase 13
Referral to GP 11
Referral for asthma/COPD review 4
Referral to falls team 4
No changes made during SMR 3
Re-initiation of meds 3
Reviews declined 3
Referral to continence clinic 2
Referral to talking therapies 2
Referral to occupational therapist 2
Anticholinergic burden score reduction 1
Change in formulation 1
Change to medication 1
Compliance aid requested 1
Referral made (other) 10
Steroid card initiation 1
TOTAL 144
Number stopped
Warfarin 1
Paracetamol 1
Creams / emollients 3
PPIs (Lansoprazole / Omeprazole) 5
OTC preparations 2
Braltus 1
Fostair 1
Bisoprolol 1
Furosemide 1
Allevyn dressings 1
Eye drops / ointments 3
Temazepam 1
Betnovate scalp application 1
Senna 3
Calci-D 2
Digoxin 1
Doxazosin 1
Amlodipine 1
Clopidogrel 1
Quetiapine 1
Atorvastatin 1
Macrogol 1
Alendronic 1
Rosuvastatin 1
Gliclazide 1
Zapain 1
Clexane 1
Doxycycline 1
Prednisolone 1
Symbicort 1
Ipratopium 1
Ensure supplements 1
Sildenafil 1
Cyclizine 1
Folic acid 1
Hibiscrub 1